Essential hypertension

Last updated

Essential hypertension
Other namesPrimary hypertension
Specialty Cardiology   OOjs UI icon edit-ltr-progressive.svg

Essential hypertension (also called primary hypertension, or idiopathic hypertension) is a form of hypertension without an identifiable physiologic cause. [1] [2] It is the most common type affecting 85% of those with high blood pressure. [3] [4] The remaining 15% is accounted for by various causes of secondary hypertension. [3] Essential hypertension tends to be familial and is likely to be the consequence of an interaction between environmental and genetic factors. Hypertension can increase the risk of cerebral, cardiac, and renal events. [5]

Contents

Classification

The variation in pressure in the left ventricle (blue line) and the aorta (red line) over two cardiac cycles ("heart beats"), showing the definitions of systolic and diastolic pressure Cardiac cycle pressure only.png
The variation in pressure in the left ventricle (blue line) and the aorta (red line) over two cardiac cycles ("heart beats"), showing the definitions of systolic and diastolic pressure

Blood pressure is classified as normal blood pressure, prehypertension, hypertension (stages I and II), and isolated systolic hypertension, which is a common occurrence among the elderly. These readings are based on the average of seated blood pressure readings that were properly measured during 2 or more office visits. In adults, hypertension is considered to be present when a person's blood pressure is consistently at least 140 mmHg systolic or 90 mmHg diastolic. Patients with blood pressures over 130/80 mmHg along with Type 1 or Type 2 diabetes, or kidney disease require further treatment. [6]

ClassificationSystolic pressureDiastolic pressure
mmHg kPa (kN/m2)mmHgkPa (kN/m2)
Normal90–11912–15.960–798.0–10.5
Prehypertension120–13916.1–18.580–8910.8–11.9
Stage 1140–15918.7–21.290–9912.0–13.2
Stage 2≥160≥21.3≥100≥13.3
Isolated systolic
hypertension 		≥140≥18.7<90<12.0
Source: American Heart Association (2003). [6]

Resistant hypertension is defined as the failure to reduce blood pressure to normal levels following an adequate trial of three antihypertensive medications. [6] Guidelines for treating resistant hypertension have been published in the UK, and US. [7]

Risk factors

The etiology of hypertension differs widely amongst individuals within a large population. [8] While essential hypertension has no identifiable cause, several risk factors have been identified.

Genetics

Having a personal family history of hypertension increases the likelihood that an individual develops it. [9] More than 50 genes have been examined in association studies with hypertension, and the number is constantly growing. One of these genes is the angiotensinogen (AGT) gene, studied extensively by Kim et al. They showed that increasing the number of AGT increases the blood pressure and hence this may cause hypertension. [8] In single variant tests, it has been shown that SNPs were enriched for variants associated with adiposity, type 2 diabetes, coronary heart disease and kidney function in previously published GWAS, providing evidence that genetic loci related to blood pressure contribute to cardiovascular outcomes. [10] Twins have been included in studies measuring ambulatory blood pressure; from these studies it has been suggested that there is a large genetic influence on essential hypertension. [8] Supporting data has emerged from animal studies as well as clinical studies in human populations. The majority of these studies support the concept that the inheritance is probably multifactorial or that a number of different genetic defects each has an elevated blood pressure as one of its phenotypic expressions. However, the genetic influence on hypertension is not fully understood at the moment. It is believed that linking hypertension-related phenotypes with specific variations of the genome may yield definitive evidence of heritability. [11] Another view is that hypertension can be caused by mutations in single genes, inherited on a Mendelian basis. [12]

Race

In the United States, essential hypertension is four times more common in black than white people, accelerates more rapidly and is often more severe with higher mortality in black patients.There are numerous racial inequities that contribute to black individuals having higher prevalence of essential hypertension than white people. These racial disparity-related risk factors are less conspicuous. Discrimination may have both a direct and indirect effect on hypertension. Chronic stress, like that caused by discrimination, has been linked to a number of health problems. Access to social, financial, and educational resources that can enhance one's health is unequally impacted by racial prejudice. Numerous studies have demonstrated the connection between feeling discriminated against and having elevated blood pressure. In comparison to participants who reported low levels of lifetime discrimination, a study from the Jackson Heart Study indicated that those people who reported high or medium levels of prejudice were more likely to acquire hypertension. Racial inequities are rarely acknowledged as significant risk factors in the healthcare industry. [13] [14] [15] [9] [16] [17] [18]

Diet

An unhealthy diet, which includes excessive consumption of unhealthy food, is a recognized risk factor for hypertension. A balanced diet is recommended for both its prevention and control. [19] Dietary sodium intake also contributes to blood pressure. Approximately one third of the essential hypertensive population is responsive to sodium intake. [20] [21] When sodium intake exceeds the capacity of the body to excrete it through the kidneys, blood volume will expand due to movement of fluids by osmosis into the blood vessels. This causes the arterial pressure to rise as the cardiac output will increase. Local autoregulatory mechanisms counteract this by increasing the vascular resistance to blood flow in order to maintain normal pressure in the capillary blood vessels . As arterial pressure increases in response to high sodium chloride intake, urinary sodium excretion increases but this higher excretion of salt is maintained at the expense of increased arterial blood pressure. [9] The increased sodium ion concentration stimulates ADH and thirst mechanisms, leading to increased reabsorption of water in the kidneys, a concentrated urine, and thirst with a higher intake of water.

Aging

Hypertension can also be age-related when associated with a western diet and lifestyle, and if this is the case, it is likely to be multifactorial. [22] One possible mechanism involves a reduction in vascular compliance due to the stiffening of the arteries. This can build up due to isolated systolic hypertension with a widened pulse pressure. A decrease in glomerular filtration rate is related to aging and this results in decreasing efficiency of sodium excretion. The developing of certain diseases such as renal microvascular disease and capillary rarefaction may relate to this decrease in efficiency of sodium excretion. There is experimental evidence that suggests that renal microvascular disease is an important mechanism for inducing salt-sensitive hypertension. [23]

Obesity

Obesity can increase the risk of hypertension to fivefold as compared with normal weight, and up to two-thirds of hypertension cases can be attributed to excess weight. [24] More than 85% of cases occur in those with a Body mass index (BMI) greater than 25. [24] A definitive link between obesity and hypertension has been found using animal and clinical studies; from these it has been realized that many mechanisms are potential causes of obesity-induced hypertension. These mechanisms include the activation of the sympathetic nervous system as well as the activation of the renin–angiotensin–aldosterone system. [25]

Alcohol

Excessive alcohol consumption can increase blood pressure over time. Alcohol also contains a high density of calories and may contribute to obesity. [26]

Renin

Renin elevation is another risk factor. Renin is an enzyme secreted by the juxtaglomerular apparatus of the kidney and indirectly stimulates the release of aldosterone . Consequently, some hypertensive patients have been defined as having low-renin and others as having essential hypertension. Low-renin hypertension is more common in African Americans than white Americans, and may explain why African Americans tend to respond better to diuretic therapy than drugs that interfere with the renin–angiotensin system. [27]

Diabetes

Insulin resistance and/or hyperinsulinemia, can also contribute to hypertension. Insulin is a polypeptide hormone secreted by cells in the islets of Langerhans, which are contained throughout the pancreas. Its main purpose is to regulate the levels of glucose in the body antagonistically with glucagon through negative feedback loops. Insulin resistance can lead to increased arterial stiffening, inappropriate activation of the renin-angiotensin system, and inappropriate activation of the sympathetic nervous system. [28]

Smoking

Smoking directly causes a temporary increase in blood pressure through activation of the sympathetic nervous system by nicotine. Chronic tobacco use is also linked to a variety of medical conditions including coronary artery disease, pulmonary disease, cancer, and stroke. [29]

Vitamin deficiency

It has been suggested that vitamin D deficiency is associated with cardiovascular risk factors. [30] It has been observed that individuals with a vitamin D deficiency have higher systolic and diastolic blood pressures than average. Vitamin D inhibits renin secretion and its activity, it therefore acts as a "negative endocrine regulator of the renin–angiotensin system". Hence, a deficiency in vitamin D leads to an increase in renin secretion. This is one possible mechanism of explaining the observed link between hypertension and vitamin D levels in the blood plasma. [31]

Also, some authorities claim that potassium might both prevent and treat hypertension. [32]

Lack of exercise

Regular physical exercise reduces blood pressure. The UK National Health Service advises 150 minutes (2 hours and 30 minutes) of moderate-intensity aerobic activity per week to help prevent hypertension. [26]

Pathophysiology

A diagram explaining factors affecting arterial pressure Arterial pressure diagram.png
A diagram explaining factors affecting arterial pressure

Cardiac output and peripheral resistance are the two determinants of arterial pressure and so blood pressure is normally dependent on the balance between cardiac output and peripheral resistance. [33] Cardiac output is determined by stroke volume and heart rate; stroke volume is related to myocardial contractility and to the size of the vascular compartment. Peripheral resistance is determined by functional and anatomic changes in small arteries and arterioles. The pathophysiology of essential hypertension is an area of research, and until now remains not well understood, but many theories have been proposed to explain this.[ citation needed ]

What is known is that cardiac output is raised early in the disease course, with total peripheral resistance (TPR) normal; over time cardiac output drops to normal levels but TPR is increased. Three theories have been proposed to explain this:[ citation needed ]

It is also known that hypertension is highly heritable and polygenic (caused by more than one gene) and a few candidate genes have been postulated in the etiology of this condition. [34] [35] [36] [37]

Essential hypertension can lead to impaired white matter of the brain, which is accompanied by specific cognitive impairment. [38]

Diagnosis

For most patients, health care providers diagnose high blood pressure when blood pressure readings are consistently 140/90 mmHg or above. A blood pressure test can be done in a health care provider's office or clinic. To track blood pressure readings over a period of time, the health care provider may ask the patient to come into the office on different days and at different times. The health care provider also may ask the patient to check readings at home or at other locations that have blood pressure equipment and to keep a written log of results. The health care provider usually takes 2–3 readings at several medical appointments to diagnose high blood pressure. [39] Using the results of the blood pressure test, the health care provider will diagnose prehypertension or high blood pressure if:

Once the health care provider determines the severity, he or she may order additional tests to determine if the blood pressure is due to other conditions, medications, or if there is primary high blood pressure. Health care providers can use this information to develop a treatment plan. [39]

History

Prior to the work of Australian cardiovascular physiologist Paul Korner, in the 1940s, little was known about essential hypertension. [40]

See also

Related Research Articles

<span class="mw-page-title-main">ACE inhibitor</span> Class of medications used primarily to treat high blood pressure

Angiotensin-converting-enzyme inhibitors are a class of medication used primarily for the treatment of high blood pressure and heart failure. This class of medicine works by causing relaxation of blood vessels as well as a decrease in blood volume, which leads to lower blood pressure and decreased oxygen demand from the heart.

<span class="mw-page-title-main">Blood pressure</span> Pressure exerted by circulating blood upon the walls of arteries

Blood pressure (BP) is the pressure of circulating blood against the walls of blood vessels. Most of this pressure results from the heart pumping blood through the circulatory system. When used without qualification, the term "blood pressure" refers to the pressure in a brachial artery, where it is most commonly measured. Blood pressure is usually expressed in terms of the systolic pressure over diastolic pressure in the cardiac cycle. It is measured in millimeters of mercury (mmHg) above the surrounding atmospheric pressure, or in kilopascals (kPa). The difference between the systolic and diastolic pressures is known as pulse pressure, while the average pressure during a cardiac cycle is known as mean arterial pressure.

<span class="mw-page-title-main">Hypertension</span> Long-term high blood pressure in the arteries

Hypertension, also known as high blood pressure, is a long-term medical condition in which the blood pressure in the arteries is persistently elevated. High blood pressure usually does not cause symptoms. It is, however, a major risk factor for stroke, coronary artery disease, heart failure, atrial fibrillation, peripheral arterial disease, vision loss, chronic kidney disease, and dementia. Hypertension is a major cause of premature death worldwide.

<span class="mw-page-title-main">Angiotensin</span> Group of peptide hormones in mammals

Angiotensin is a peptide hormone that causes vasoconstriction and an increase in blood pressure. It is part of the renin–angiotensin system, which regulates blood pressure. Angiotensin also stimulates the release of aldosterone from the adrenal cortex to promote sodium retention by the kidneys.

<span class="mw-page-title-main">Pulse pressure</span> Difference between systolic and diastolic blood pressure

Pulse pressure is the difference between systolic and diastolic blood pressure. It is measured in millimeters of mercury (mmHg). It represents the force that the heart generates each time it contracts. Healthy pulse pressure is around 40 mmHg. A pulse pressure that is consistently 60 mmHg or greater is likely to be associated with disease, and a pulse pressure of 50 mmHg or more increases the risk of cardiovascular disease. Pulse pressure is considered low if it is less than 25% of the systolic. A very low pulse pressure can be a symptom of disorders such as congestive heart failure.

Antihypertensives are a class of drugs that are used to treat hypertension. Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke, heart failure, kidney failure and myocardial infarction. Evidence suggests that reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34% and of ischaemic heart disease by 21%, and can reduce the likelihood of dementia, heart failure, and mortality from cardiovascular disease. There are many classes of antihypertensives, which lower blood pressure by different means. Among the most important and most widely used medications are thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), and beta blockers.

<span class="mw-page-title-main">Angiotensin-converting enzyme</span> Mammalian protein found in humans

Angiotensin-converting enzyme, or ACE, is a central component of the renin–angiotensin system (RAS), which controls blood pressure by regulating the volume of fluids in the body. It converts the hormone angiotensin I to the active vasoconstrictor angiotensin II. Therefore, ACE indirectly increases blood pressure by causing blood vessels to constrict. ACE inhibitors are widely used as pharmaceutical drugs for treatment of cardiovascular diseases.

<span class="mw-page-title-main">Mean arterial pressure</span> Average blood pressure in an individual during a single cardiac cycle

In medicine, the mean arterial pressure (MAP) is an average calculated blood pressure in an individual during a single cardiac cycle. Although methods of estimating MAP vary, a common calculation is to take one-third of the pulse pressure, and add that amount to the diastolic pressure. A normal MAP is about 90 mmHg.

Compliance is the ability of a hollow organ (vessel) to distend and increase volume with increasing transmural pressure or the tendency of a hollow organ to resist recoil toward its original dimensions on application of a distending or compressing force. It is the reciprocal of "elastance", hence elastance is a measure of the tendency of a hollow organ to recoil toward its original dimensions upon removal of a distending or compressing force.

<span class="mw-page-title-main">Telmisartan</span> Angiotensin II receptor antagonist

Telmisartan, sold under the brand name Micardis among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combination telmisartan/hydrochlorothiazide, telmisartan/cilnidipine and telmisartan/amlodipine.

Arterial stiffness occurs as a consequence of biological aging and arteriosclerosis. Inflammation plays a major role in arteriosclerosis development, and consequently it is a major contributor in large arteries stiffening. Increased arterial stiffness is associated with an increased risk of cardiovascular events such as myocardial infarction, hypertension, heart failure and stroke, the two leading causes of death in the developed world. The World Health Organization predicts that in 2010, cardiovascular disease will also be the leading killer in the developing world and represents a major global health problem.

Prehypertension, also known as high normal blood pressure and borderline hypertensive (BH), is a medical classification for cases where a person's blood pressure is elevated above optimal or normal, but not to the level considered hypertension. Prehypertension is now referred to as "elevated blood pressure" by the American College of Cardiology (ACC) and the American Heart Association (AHA). The ACC/AHA define elevated blood pressure as readings with a systolic pressure from 120 to 129 mm Hg and a diastolic pressure under 80 mm Hg, Readings greater than or equal to 130/80 mm Hg are considered hypertension by ACC/AHA and if greater than or equal to 140/90 mm Hg by ESC/ESH. and the European Society of Hypertension defines "high normal blood pressure" as readings with a systolic pressure from 130 to 139 mm Hg and a diastolic pressure 85-89 mm Hg.

<span class="mw-page-title-main">Pathophysiology of hypertension</span>

Pathophysiology is a study which explains the function of the body as it relates to diseases and conditions. The pathophysiology of hypertension is an area which attempts to explain mechanistically the causes of hypertension, which is a chronic disease characterized by elevation of blood pressure. Hypertension can be classified by cause as either essential or secondary. About 90–95% of hypertension is essential hypertension. Some authorities define essential hypertension as that which has no known explanation, while others define its cause as being due to overconsumption of sodium and underconsumption of potassium. Secondary hypertension indicates that the hypertension is a result of a specific underlying condition with a well-known mechanism, such as chronic kidney disease, narrowing of the aorta or kidney arteries, or endocrine disorders such as excess aldosterone, cortisol, or catecholamines. Persistent hypertension is a major risk factor for hypertensive heart disease, coronary artery disease, stroke, aortic aneurysm, peripheral artery disease, and chronic kidney disease.

<span class="mw-page-title-main">Complications of hypertension</span>

Complications of hypertension are clinical outcomes that result from persistent elevation of blood pressure. Hypertension is a risk factor for all clinical manifestations of atherosclerosis since it is a risk factor for atherosclerosis itself. It is an independent predisposing factor for heart failure, coronary artery disease, stroke, kidney disease, and peripheral arterial disease. It is the most important risk factor for cardiovascular morbidity and mortality, in industrialized countries.

<span class="mw-page-title-main">Salt and cardiovascular disease</span> Association between salt consumption and cardiovascular disease

Salt consumption has been extensively studied for its role in human physiology and impact on human health. Chronic, high intake of dietary salt consumption is associated with hypertension and cardiovascular disease, in addition to other adverse health outcomes. Major health and scientific organizations, such as the World Health Organization, US Centers for Disease Control and Prevention, and American Heart Association, have established high salt consumption as a major risk factor for cardiovascular diseases and stroke.

The African Society of Hypertension (AfSoH) Initiative is an international organization initiative with the objective to create the African Society of Hypertension with a main goal of providing a stable and organized African platform for scientific exchange in arterial hypertension. The AfSoH Initiative was created in 2010 by the consortium of health professionals and researchers active in field of arterial hypertension on African continent led by Marc Twagirumukiza. The official membership is obtained after registration.

Orthostatic hypertension is a medical condition consisting of a sudden and abrupt increase in blood pressure (BP) when a person stands up. Orthostatic hypertension is diagnosed by a rise in systolic BP of 20 mmHg or more when standing. Orthostatic diastolic hypertension is a condition in which the diastolic BP raises to 98 mmHg or over in response to standing, but this definition currently lacks clear medical consensus, so is subject to change. Orthostatic hypertension involving the systolic BP is known as systolic orthostatic hypertension.

The modern history of hypertension begins with the understanding of the cardiovascular system based on the work of physician William Harvey (1578–1657), who described the circulation of blood in his book De motu cordis. The English clergyman Stephen Hales made the first published measurement of blood pressure in 1733. Descriptions of what would come to be called hypertension came from, among others, Thomas Young in 1808 and especially Richard Bright in 1836. Bright noted a link between cardiac hypertrophy and kidney disease, and subsequently kidney disease was often termed Bright's disease in this period. In 1850 George Johnson suggested that the thickened blood vessels seen in the kidney in Bright's disease might be an adaptation to elevated blood pressure. William Senhouse Kirkes in 1855 and Ludwig Traube in 1856 also proposed, based on pathological observations, that elevated pressure could account for the association between left ventricular hypertrophy to kidney damage in Bright's disease. Samuel Wilks observed that left ventricular hypertrophy and diseased arteries were not necessarily associated with diseased kidneys, implying that high blood pressure might occur in people with healthy kidneys; however, the first report of elevated blood pressure in a person without evidence of kidney disease was made by Frederick Akbar Mahomed in 1874 using a sphygmograph. The concept of hypertensive disease as a generalized circulatory disease was taken up by Sir Clifford Allbutt, who termed the condition "hyperpiesia". However, hypertension as a medical entity really came into being in 1896 with the invention of the cuff-based sphygmomanometer by Scipione Riva-Rocci in 1896, which allowed blood pressure to be measured in the clinic. In 1905, Nikolai Korotkoff improved the technique by describing the Korotkoff sounds that are heard when the artery is ausculted with a stethoscope while the sphygmomanometer cuff is deflated. Tracking serial blood pressure measurements was further enhanced when Donal Nunn invented an accurate fully automated oscillometric sphygmomanometer device in 1981.

Hypertension is managed using lifestyle modification and antihypertensive medications. Hypertension is usually treated to achieve a blood pressure of below 140/90 mmHg to 160/100 mmHg. According to one 2003 review, reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34% and of ischaemic heart disease by 21% and reduce the likelihood of dementia, heart failure, and mortality from cardiovascular disease.

<span class="mw-page-title-main">Hypertension and the brain</span>

Hypertension is a condition characterized by an elevated blood pressure in which the long term consequences include cardiovascular disease, kidney disease, adrenal gland tumors, vision impairment, memory loss, metabolic syndrome, stroke and dementia. It affects nearly 1 in 2 Americans and remains as a contributing cause of death in the United States. There are many genetic and environmental factors involved with the development of hypertension including genetics, diet, and stress.

References

  1. ↑ "Essential hypertension - Symptoms, diagnosis and treatment | BMJ Best Practice". bestpractice.bmj.com. Retrieved July 30, 2020.
  2. ↑ Hall J (2011). Guyton and Hall textbook of medical physiology (Twelfth ed.). Saunders/Elsevier. p. 225. ISBN   978-1-4160-4574-8.
  3. 1 2 Ferri F (2019). Ferri's clinical advisor 2019 : 5 books in 1. Elsevier. p. 729. ISBN   978-0-323-53042-2.
  4. ↑ "Hypertension: eMedicine Nephrology" . Retrieved June 5, 2009.
  5. ↑ Messerli FH, Williams B, Ritz E (August 2007). "Essential hypertension". Lancet. 370 (9587): 591–603. doi:10.1016/S0140-6736(07)61299-9. PMID   17707755. S2CID   26414121.
  6. 1 2 3 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. (December 2003). "Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure". Hypertension. 42 (6): 1206–52. doi: 10.1161/01.HYP.0000107251.49515.c2 . PMID   14656957.
  7. ↑ Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. (June 2008). "Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research". Hypertension. 51 (6): 1403–19. doi: 10.1161/HYPERTENSIONAHA.108.189141 . PMID   18391085.
  8. 1 2 3 Dickson ME, Sigmund CD (July 2006). "Genetic basis of hypertension: revisiting angiotensinogen". Hypertension. 48 (1): 14–20. doi: 10.1161/01.HYP.0000227932.13687.60 . PMID   16754793.
  9. 1 2 3 Loscalzo J, Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL (2008). Harrison's principles of internal medicine. McGraw-Hill Medical. ISBN   978-0-07-147691-1.
  10. ↑ Kato N, Loh M, Takeuchi F, Verweij N, Wang X, Zhang W, et al. (November 2015). "Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation". Nature Genetics. 47 (11): 1282–1293. doi:10.1038/ng.3405. PMC   4719169 . PMID   26390057.
  11. ↑ Kotchen TA, Kotchen JM, Grim CE, George V, Kaldunski ML, Cowley AW, et al. (July 2000). "Genetic determinants of hypertension: identification of candidate phenotypes". Hypertension. 36 (1): 7–13. CiteSeerX   10.1.1.560.4838 . doi:10.1161/01.HYP.36.1.7. PMID   10904005. Archived from the original on July 8, 2012.
  12. ↑ Williams B, et al. (British Hypertension Society) (2006). Sutters M (ed.). "Hypertension Etiology & Classification – Secondary Hypertension". Armenian Medical Network. Retrieved December 2, 2007.
  13. ↑ Wazlowski S (September 1, 2020). "Study: Racial discrimination can increase hypertension in blacks". The Nation's Health. 50 (7): 5.
  14. ↑ Hedgepeth C (September 21, 2020). "Discrimination, high blood pressure, and health disparities in African Americans". Harvard Health.
  15. ↑ Lackland DT (2014). "Racial differences in hypertension: Implications for high blood pressure management". The American Journal of the Medical Sciences. 348 (2): 135–138. doi:10.1097/MAJ.0000000000000308. PMC   4108512 . PMID   24983758.
  16. ↑ Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (July 1998). "Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction". The New England Journal of Medicine. 339 (4): 229–34. doi: 10.1056/NEJM199807233390404 . PMID   9673301.
  17. ↑ Lindhorst J, Alexander N, Blignaut J, Rayner B (2007). "Differences in hypertension between blacks and whites: an overview". Cardiovascular Journal of Africa. 18 (4): 241–7. PMC   4170224 . PMID   17940670.
  18. ↑ Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. (March 1995). "Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991". Hypertension. 25 (3): 305–13. doi:10.1161/01.HYP.25.3.305. PMID   7875754. Archived from the original on December 5, 2012.
  19. ↑ Mills KT, Stefanescu A, He J (February 2020). "The global epidemiology of hypertension". Nature Reviews Nephrology. 16 (4): 223–237. doi:10.1038/s41581-019-0244-2. PMC   7998524 . PMID   32024986.
  20. ↑ http://www.jstage.jst.go.jp/article/jphs/100/5/370/_pdf%5B%5D A Missing Link Between a High Salt Intake and Blood Pressure Increase: Makoto Katori and Masataka Majima, Department of Pharmacology, Kitasato University School of Medicine, Kitasato, Sagamihara, Kanagawa, Japan February 8, 2006
  21. ↑ http://hyper.ahajournals.org/content/27/3/481.full Salt Sensitivity of Blood Pressure in Humans Myron H. Weinberger Indiana University School of Medicine, Hypertension 1996 doi:10.1161/01.HYP.27.3.481
  22. ↑ Carrera-Bastos P, Fontes-Villalba M, O'Keefe JH, Lindeberg S, Cordain L (March 9, 2011). "The western diet and lifestyle and diseases of civilization". Research Reports in Clinical Cardiology. 2: 15–35. doi: 10.2147/RRCC.S16919 . S2CID   3231706 . Retrieved February 9, 2021.
  23. ↑ Kosugi T, Nakagawa T, Kamath D, Johnson RJ (February 2009). "Uric acid and hypertension: an age-related relationship?". Journal of Human Hypertension. 23 (2): 75–6. doi: 10.1038/jhh.2008.110 . PMID   18754017. S2CID   20887832.
  24. 1 2 Haslam DW, James WP (October 2005). "Obesity". Lancet. 366 (9492): 1197–209. doi:10.1016/S0140-6736(05)67483-1. PMID   16198769. S2CID   208791491.
  25. ↑ Rahmouni K, Correia ML, Haynes WG, Mark AL (January 2005). "Obesity-associated hypertension: new insights into mechanisms". Hypertension. 45 (1): 9–14. doi:10.1161/01.HYP.0000151325.83008.b4. PMID   15583075.
  26. 1 2 "Prevention". nhs.uk. October 23, 2017. Retrieved April 11, 2018.
  27. ↑ Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. (June 2020). "2020 International Society of Hypertension Global Hypertension Practice Guidelines". Hypertension. 75 (6): 1334–1357. doi:10.1161/HYPERTENSIONAHA.120.15026. ISSN   0194-911X. PMID   32370572.
  28. ↑ Jia G, Sowers JR (November 2021). "Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease". Hypertension. 78 (5): 1197–1205. doi:10.1161/HYPERTENSIONAHA.121.17981. ISSN   0194-911X. PMC   8516748 . PMID   34601960.
  29. ↑ Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health (2010), "Cardiovascular Diseases", How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General, Centers for Disease Control and Prevention (US), retrieved February 8, 2024
  30. ↑ Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF (December 2008). "Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?". Journal of the American College of Cardiology. 52 (24): 1949–56. doi:10.1016/j.jacc.2008.08.050. PMID   19055985.
  31. ↑ Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, et al. (May 2007). "Plasma 25-hydroxyvitamin D levels and risk of incident hypertension". Hypertension. 49 (5): 1063–9. doi: 10.1161/HYPERTENSIONAHA.107.087288 . PMID   17372031.
  32. ↑ Eva May Nunnelley Hamilton, Eleanor Noss Whitney, Frances Sienkiewicz Sizer (1991). Fifth Edition Annotated Instructor's Edition Nutrition Concepts & Controversies. West Publishing Company. ISBN   978-0-314-81092-2. OCLC   22451334.
  33. ↑ Klabunde RE (2007). "Cardiovascular Physiology Concepts – Mean Arterial Pressure" . Retrieved September 29, 2008.
  34. ↑ Sagnella GA, Swift PA (June 2006). "The renal epithelial sodium channel: genetic heterogeneity and implications for the treatment of high blood pressure". Current Pharmaceutical Design. 12 (18): 2221–34. doi:10.2174/138161206777585157. PMID   16787251.
  35. ↑ Johnson JA, Turner ST (June 2005). "Hypertension pharmacogenomics: current status and future directions". Current Opinion in Molecular Therapeutics. 7 (3): 218–25. PMID   15977418.
  36. ↑ Izawa H, Yamada Y, Okada T, Tanaka M, Hirayama H, Yokota M (May 2003). "Prediction of genetic risk for hypertension". Hypertension. 41 (5): 1035–40. doi:10.1161/01.HYP.0000065618.56368.24. PMID   12654703. S2CID   18017653.
  37. ↑ Bello Inumidun Taofik (2017). diagnosis impact of hypertension
  38. ↑ Pervichko E, Ostroumova T, Darevskaya M, Perepelova E, Perepelov V, Vartanov A, et al. (2018). "A psychophysiological study ofcognitive disorders in naivemiddle-age patients withuncomplicated essential hypertensionand white matter lesions". European Psychiatry. 48S: 114.
  39. 1 2 3 "Diagnosis of High Blood Pressure - NHLBI, NIH". National Institutes of Health. March 24, 2022.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  40. ↑ "World authority on blood pressure: Paul Korner". Sydney Morning Herald. Fairfax Media. November 30, 2012.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.